Olanzapine exposure diminishes perfusion and decreases volume of sensorimotor cortex in rats

0508988 - ÚPT 2020 RIV PL eng J - Článek v odborném periodiku
Dražanová, Eva - Krátká, Lucie - Vaškovicová, Naděžda - Skoupý, Radim - Horská, K. - Babinská, Z. - Kotolová, H. - Vrlíková, Lucie - Buchtová, Marcela - Starčuk jr., Zenon - Rudá-Kučerová, J.
Olanzapine exposure diminishes perfusion and decreases volume of sensorimotor cortex in rats.
Pharmacological Reports. Roč. 71, č. 5 (2019), s. 839-847. ISSN 1734-1140. E-ISSN 2299-5684
Grant CEP: GA MZd(CZ) NV16-30299A; GA MŠMT(CZ) LO1212; GA MŠMT(CZ) EF16_013/0001775; GA MŠMT(CZ) LM2015062
Institucionální podpora: RVO:68081731 ; RVO:67985904
Klíčová slova: arterial spin labelling * cortex * Leptin * Olanzapine * Sprague-Dawley rats
Obor OECD: Pharmacology and pharmacy; Developmental biology (UZFG-Y)
Impakt faktor: 2.754, rok: 2019
Způsob publikování: Omezený přístup
https://www.sciencedirect.com/science/article/abs/pii/S1734114019300714?via%3Dihub

Background: Olanzapine is a frequently used atypical antipsychotic drug known to exert structural brain alterations in animals. This study investigated whether chronic olanzapine exposure alters regional blood brain perfusion assessed by Arterial Spin Labelling (ASL) magnetic resonance imaging (MRI) in a validated model of olanzapine-induced metabolic disturbances. An effect of acute olanzapine exposure on brain perfusion was also assessed for comparison. Methods: Adult Sprague-Dawley female rats were treated by intramuscular depot olanzapine injections (100 mg/kg every 14 days) or vehicle for 8 weeks. ASL scanning was performed on a 9.4 T Bruker BioSpec 94/30USR scanner under isoflurane anesthesia. Serum samples were used to assay leptin and TNF-α level while brains were sliced for histology. Another group received only one non-depot intraperitoneal dose of olanzapine (7 mg/kg) during MRI scanning, thus exposing its acute effect on brain perfusion. Results: Both acute and chronic dosing of olanzapine resulted in decreased perfusion in the sensorimotor cortex, while no effect was observed in the piriform cortex or hippocampus. Furthermore, in the chronically treated group decreased cortex volume was observed. Chronic olanzapine dosing led to increased body weight, adipose tissue mass and leptin level, confirming its expected metabolic effects. Conclusion: This study demonstrates region-specific decreases in blood perfusion associated with olanzapine exposure present already after the first dose. These findings extend our understanding of olanzapine-induced functional and structural brain changes.
Trvalý link: http://hdl.handle.net/11104/0299810